STRUCTURAL STUDIES OF NUCLEOSIDE DIPHOSPHATE KINASE
核苷二磷酸激酶的结构研究
基本信息
- 批准号:2143692
- 负责人:
- 金额:$ 5.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-15 至 1997-08-31
- 项目状态:已结题
- 来源:
- 关键词:X ray crystallography adenosine diphosphate adenosine monophosphate adenosine triphosphate antineoplastics antiviral agents computer simulation crystallization cytosine nucleotides enzyme activity enzyme inhibitors enzyme mechanism enzyme structure enzyme substrate enzyme substrate analog enzyme substrate complex guanosine diphosphate guanosine monophosphate nucleoside diphosphate kinase nucleotide analog phosphoproteins phosphorylation site directed mutagenesis
项目摘要
The broad long-term objective of the proposed work is to determine the
structure and understand the catalytic mechanism of nucleoside diphosphate
(NDF) kinase, an enzyme that plays a key role in nucleotide metabolism.
Exciting new research is beginning to shed light on the enzyme's ability
to suppress metastasis as well as its ability to regulate the composition
of nucleotide pools. Structural analyses of these proteins will provide a
foundation for modulating the cellular functions incumbent upon this
enzyme as well as providing a basis for improving the anti-neoplastic and
anti-viral properties of some nucleotide analogs.
We have recently determined the 2.0 Angstrom resolution X-ray
crystallographic structure of the Myxococcus xanthus enzyme. We have a
crystal form of the enzyme that is enzymatically active. With these
crystals, we have been able to collect 1.7 Angstrom resolution data for
complexes of the enzyme with nucleotides. The structures of the complexes
reveal that the enzyme has a novel nucleotide binding motif that is quite
different than two predictions for the mode of nucleotide binding-one
based upon the sequence analysis and one based upon the structure of an
inactive mutant of the Dictyostelium discoideum NDF kinase.
The NDP kinases function via a ping-pong mechanism in which an
autophosphorylated enzyme intermediate is formed. The intermediate of the
enzymatic mechanism is a phosphohistidine. The structure suggests a
mechanism for this phosphorylation. Though many enzymes form
phosphohistidine intermediates, no structure has been determined for any
of them. We have been able to stabilize the NDP kinase phosphoenzyme
intermediate sufficiently for X-ray crystallographic data collection.
Based on structural information, we are examining the roles of active-site
mutants by site-directed mutagenesis and steady-state enzyme kinetics.
We will determine the three-dimensional structures of NDP kinase complexed
with each of 12 different substrates and inhibitors. These studies of NDP
kinase-substrate complexes will provide a structural basis for rational
design of more effective nucleotide analogs of anti-neoplastic and anti-
viral importance.
Human and murine NDP kinase Nm23 is a suppressor of metastasis in some
cell types. We have obtained crystals of a human NDP kinase, Nm23-H2. In
addition to its enzymatic activity, Nm23-H2 is a DNA-binding protein that
is a specific transcriptional activator of the c-myc oncogene in vitro.
These crystals diffract to a resolution limit of 3.0 Angstrom. We will
determine the structure of the human enzyme with molecular replacement
techniques using our structure of the M. xanthus enzyme. We will also
determine the structure of a complex of Nm23-H2 with a double-stranded
oligonucleotide.
拟议工作的广泛长期目标是确定
核苷二磷酸的结构并了解其催化机制
(NDF) 激酶,一种在核苷酸代谢中起关键作用的酶。
令人兴奋的新研究开始揭示这种酶的能力
抑制转移及其调节成分的能力
核苷酸库。这些蛋白质的结构分析将提供
调节细胞功能的基础
酶并为提高抗肿瘤和抗肿瘤作用提供基础
一些核苷酸类似物的抗病毒特性。
我们最近确定了2.0埃分辨率的X射线
黄色粘球菌酶的晶体结构。我们有一个
具有酶活性的酶的晶体形式。有了这些
晶体,我们已经能够收集 1.7 埃分辨率的数据
酶与核苷酸的复合物。配合物的结构
揭示该酶具有一个新颖的核苷酸结合基序,该基序非常
与核苷酸结合模式的两种预测不同 - 一种
基于序列分析和基于结构的分析
盘基网柄菌 NDF 激酶的失活突变体。
NDP 激酶通过乒乓机制发挥作用,其中
形成自磷酸化酶中间体。的中间体为
酶促机制是磷酸组氨酸。该结构表明
这种磷酸化的机制。尽管许多酶形成
磷酸组氨酸中间体,尚未确定任何结构
其中。 我们已经能够稳定 NDP 激酶磷酸酶
足以进行 X 射线晶体学数据收集的中间体。
根据结构信息,我们正在研究活性位点的作用
通过定点诱变和稳态酶动力学产生突变体。
我们将确定NDP激酶复合物的三维结构
具有 12 种不同底物和抑制剂中的每一种。新民主党的这些研究
激酶-底物复合物将为合理的
设计更有效的抗肿瘤和抗肿瘤的核苷酸类似物
病毒的重要性。
人和鼠 NDP 激酶 Nm23 是某些肿瘤转移的抑制因子
细胞类型。我们获得了人类 NDP 激酶 Nm23-H2 的晶体。在
除了其酶活性外,Nm23-H2 是一种 DNA 结合蛋白,
是体外 c-myc 癌基因的特异性转录激活剂。
这些晶体的衍射分辨率极限为 3.0 埃。我们将
通过分子置换确定人体酶的结构
使用我们的 M. xanthus 酶结构的技术。我们还将
确定具有双链的 Nm23-H2 复合物的结构
寡核苷酸。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROGER L WILLIAMS其他文献
ROGER L WILLIAMS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROGER L WILLIAMS', 18)}}的其他基金
STRUCTURAL STUDIES OF NUCLEOSIDE DIPHOSPHATE KINASE
核苷二磷酸激酶的结构研究
- 批准号:
2143694 - 财政年份:1994
- 资助金额:
$ 5.46万 - 项目类别:
STRUCTURAL STUDIES OF NUCLEOSIDE DIPHOSPHATE KINASE
核苷二磷酸激酶的结构研究
- 批准号:
2143693 - 财政年份:1994
- 资助金额:
$ 5.46万 - 项目类别:
BIOEQUIVALENCE AND PROTEIN BINDING OF DISOPYRAMIDE
丙吡胺的生物等效性和蛋白质结合
- 批准号:
4700357 - 财政年份:
- 资助金额:
$ 5.46万 - 项目类别:
ABSORPTION AND DISPOSITION OF 14C RADIOLABELLED CELIPROLOL
14C 放射性标记的塞利洛尔的吸收和处置
- 批准号:
4700355 - 财政年份:
- 资助金额:
$ 5.46万 - 项目类别:
BIOEQUIVALENCE OF FORMULATIONS OF SPIRONOLACTONE AND HYDROCHLOROTHIAZINE
螺内酯和氢氯噻嗪制剂的生物等效性
- 批准号:
4700290 - 财政年份:
- 资助金额:
$ 5.46万 - 项目类别:
相似海外基金
Mitochondrial Creatine Kinase-deficient Mice: Effects on Adenosine Diphosphate Transport and Metabolic Homeostasis during Exercise
线粒体肌酸激酶缺陷小鼠:运动过程中对二磷酸腺苷转运和代谢稳态的影响
- 批准号:
480897-2015 - 财政年份:2015
- 资助金额:
$ 5.46万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
The mechanism of adenosine diphosphate receptor mediated thrombus formation in antiphospholipid syndrome.
抗磷脂综合征中二磷酸腺苷受体介导血栓形成的机制。
- 批准号:
25670455 - 财政年份:2013
- 资助金额:
$ 5.46万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research














{{item.name}}会员




